AXSM vs VMC · rev $409.6M vs P/E 35, rev $7.94B
Axsome Therapeutics Inc (AXSM) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported VMC revenue for 2025-12-31 was $7.94B. Net income was $1.08B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
AXSM currently screens at market cap $11.96B. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the AXSM and VMC stock pages for the full models.
Not investment advice.